Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Avania, a full-service global MedTech contract research organization (“CRO”), announced that Astorg has acquired a majority stake in the company.
read more
Astorg and International Chemical Investors Group (ICIG) have signed a binding agreement whereby Astorg will acquire CordenPharm from ICIG. As part of the transaction, the founders will take the opportunity to reinvest as partners with Astorg.
read more
Tuesday, January 27, 2026
Astoriom has expanded its sample management capabilities in the US with the acquisition of Precision Stability Storage. This acquisition marks a strategic expansion of Astoriom’s footprint in North America, strengthening its presence in high-growth ...
read more
Thursday, January 09, 2025
Astraveus SAS announced the successful end-to-end production of CAR-T cells within a microfluidic benchtop system. Astraveus has been able to demonstrate the potential of its unique microfluidic cell therapy processing approach, which has the ability...
read more
Thursday, December 17, 2015
AstraZeneca has entered into an agreement to invest in a majority equity stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US.
read more
Wednesday, September 02, 2015
AstraZeneca has announced that its global biologics research and development arm, MedImmune, has entered an agreement granting Daiichi Sankyo Company, Ltd. (Daiichi Sankyo) an exclusive license to develop and commercialize FluMist® Quadrivalent in ...
read more
AstraZeneca and Incyte Corporation have announced a new collaboration to evaluate the efficacy and safety of Incyte’sJanus-associated kinase (JAK) 1 inhibitor, INCB39110, in combination with AstraZeneca’s next generation epidermal growth factor ...
read more
AstraZeneca and Eli Lilly and Company have entered into a clinical trial collaboration to evaluate the safety and preliminary efficacy of AstraZeneca’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with ramucirumab ...
read more
Wednesday, September 02, 2015
AstraZeneca has announced positive topline results from RECAPTURE 1 and RECAPTURE 2, the pivotal Phase III studies evaluating the antibiotic, CAZ-AVI (ceftazidime-avibactam), as a treatment for adult hospitalized patients with complicated Urinary ...
read more
AstraZeneca has announced that Pam P. Cheng has joined the Company as Executive Vice President, Operations and IT. Pam will succeed David Smith, who is retiring after nearly ten years with AstraZeneca.
read more
Wednesday, December 16, 2015
AstraZeneca, along with MedImmune, its global biologics research and development arm, has announced a range of strategic initiatives to accelerate the delivery of innovative biologics and targeted medicines to patients in China, the company’s second ...
read more
Monday, February 29, 2016
AstraZeneca has entered into a licensing agreement with China Medical System Holdings Ltd (CMS) for the commercialization rights in China to its calcium channel blocker, Plendil (felodipine).
read more
Monday, November 20, 2023
AstraZeneca has unveiled Evinova, a cutting-edge digital health solutions provider aimed at addressing the diverse needs of healthcare professionals, regulatory bodies, and patients. With steadfast support from AstraZeneca and strategic partnerships ...
read more
Tuesday, November 24, 2020
CCT Research announced its partnership with AstraZeneca to advance COVID-19 research. Together with local healthcare providers, CCT will facilitate clinical trials for the AZD1222 COVID-19 VACCINE, an investigational vaccine for the prevention of ...
read more
Tuesday, October 01, 2019
N-SIDE announced AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials.
read more